Collectively, these findings demonstrate that PLK1 facilitates JAK1-mediated STAT3 phosphorylation, and its inhibition disrupts the STAT3-PLK1 regulatory axis, thereby enhancing EGFR-TKI-induced cell death in EGFR-mutant NSCLC. Here, JAK1 is linked to non-small cell lung carcinoma.